Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Aptose Biosciences Inc. (T.APS) had Stock-Based Compensation of 0.47M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
-7.96M |
|
-- |
|
-- |
|
-- |
|
-7.84M |
|
-- |
|
-7.96M |
|
-7.96M |
|
-7.96M |
|
-7.96M |
|
-7.96M |
|
-7.96M |
|
-7.84M |
|
-7.70M |
|
2.13M |
|
2.13M |
|
-3.75 |
|
-3.75 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
10.72M |
|
-- |
|
-- |
|
-- |
|
21.34M |
|
-10.62M |
|
-10.62M |
|
-10.62M |
|
2.55M |
|
| Cash Flow Statement Financials | |
-4.01M |
|
-- |
|
1.19M |
|
9.63M |
|
6.81M |
|
-2.82M |
|
|
Stock-Based Compensation |
0.47M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
74.98% |
|
74.98% |
|
-74.23% |
|
74.98% |
|
-4.16 |
|
-1.89 |
|
-1.89 |
|